期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 388, 期 14, 页码 1252-1254出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMp2215609
关键词
-
Efforts to increase diversity in clinical trials should prioritize improving the trustworthiness and fairness of U.S. health care, rather than solely focusing on knowledge generation.
Why Diverse Clinical Trial Participation Matters For efforts focused on increasing diversity in clinical trials, the promise of knowledge generation shouldn't overshadow the goals of improving the trustworthiness and fairness of U.S. health care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据